Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Jan;31(1):413–418. doi: 10.1128/iai.31.1.413-418.1981

Evans blue dye adjuvant enhances delayed hypersensitivity while blocking immunity to Mycobacterium tuberculosis in mice.

D W Anderson, A J Crowle
PMCID: PMC351799  PMID: 7012002

Abstract

Evans blue dye functions as an adjuvant with protein antigens in saline to induce cell-mediated immunological responses in mice. But when used to help induce cell-mediated tuberculoimmunity, it decreased mouse resistance to tuberculosis instead of helping induce immunity. This paradox was investigated. As could be expected from previous work with other antigens, the dye did promote induction of delayed hypersensitivity in mice to tuberculoprotein when injected in saline with killed tubercle bacilli. Peritoneal macrophages from mice injected with the dye responded normally to migration inhibition factor. Morphologically, these cells were moderately "activated" compared with similar cells taken from untreated mice. However, such cells incubated with tuberculosis growth inhibition lymphokine in an in vitro test for tuberculoimmunity did not express tuberculoimmunity, whereas macrophages from untreated mice did. Therefore, Evans blue dye did promote induction of cell-mediated immunological responses and tuberculoimmunity in lymphocytes, but under the conditions used in these experiments, it also blocked expression of tuberculoimmunity by macrophages.

Full text

PDF
413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arora M. P., Crowle A. J. Adjuvanticity of Evans blue dye: preliminary characterization of its mechanisms and mode of application in mice. J Reticuloendothel Soc. 1978 Sep;24(3):271–286. [PubMed] [Google Scholar]
  2. Barksdale L., Kim K. S. Mycobacterium. Bacteriol Rev. 1977 Mar;41(1):217–372. doi: 10.1128/br.41.1.217-372.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beck F., Lloyd J. B., Griffiths A. Lysosomal enzyme inhibition by trypan blue: a theory of teratogenesis. Science. 1967 Sep 8;157(3793):1180–1182. doi: 10.1126/science.157.3793.1180. [DOI] [PubMed] [Google Scholar]
  4. Bomford R. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin Exp Immunol. 1980 Feb;39(2):435–441. [PMC free article] [PubMed] [Google Scholar]
  5. CROWLE A. J. Lung density as a measure of tuberculous involvement in mice. Am Rev Tuberc. 1958 Apr;77(4):681–693. doi: 10.1164/artpd.1958.77.4.681. [DOI] [PubMed] [Google Scholar]
  6. CROWLE A. J. Tubercle bacillary extracts immunogenic for mice. 2. Water-soluble proteinaceous extracts. Tubercle. 1961 Dec;42:479–486. doi: 10.1016/s0041-3879(61)80137-2. [DOI] [PubMed] [Google Scholar]
  7. Cahall D. L., Youmans G. P. Conditions for production, and some characteristics, of mycobacterial growth inhibitory factor produced by spleen cells from mice immunized with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis. Infect Immun. 1975 Oct;12(4):833–840. doi: 10.1128/iai.12.4.833-840.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crowle A. J., May M. A hanging drop macrophage function test. J Reticuloendothel Soc. 1978 Aug;24(2):169–185. [PubMed] [Google Scholar]
  9. Crowle A. J., May M. Preliminary demonstration of human tuberculoimmunity in vitro. Infect Immun. 1981 Jan;31(1):453–464. doi: 10.1128/iai.31.1.453-464.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davies M., Lloyd J. B., Beck F. The effect of Trypan Blue, suramin and aurothiomalate on the breakdown of 125 I-labelled albumin within rat liver lysosomes. Biochem J. 1971 Jan;121(1):21–26. doi: 10.1042/bj1210021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GRAY D. F., JENNINGS P. A. Allergy in experimental mouse tuberculosis. Am Rev Tuberc. 1955 Aug;72(2):171–195. doi: 10.1164/artpd.1955.72.2.171. [DOI] [PubMed] [Google Scholar]
  12. Hibbs J. B., Jr Activated macrophages as cytotoxic effector cells. Transplantation. 1975 Jan;19(1):77–81. doi: 10.1097/00007890-197501000-00015. [DOI] [PubMed] [Google Scholar]
  13. Hibbs J. B., Jr Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells. Science. 1974 Apr 26;184(4135):468–471. doi: 10.1126/science.184.4135.468. [DOI] [PubMed] [Google Scholar]
  14. Kripke M. L., Norbury K. C., Gruys E., Hibbs J. B., Jr Effects of trypan blue treatment on the immune responses of mice. Infect Immun. 1977 Jul;17(1):121–129. doi: 10.1128/iai.17.1.121-129.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schen R. J., Rabinovitz M., Goldschmid A., Tenne M. The affinity of Evans blue for the alpha-1-lipoprotein of human serum. Clin Chim Acta. 1967 Jun;16(3):445–448. doi: 10.1016/0009-8981(67)90314-2. [DOI] [PubMed] [Google Scholar]
  16. TRUMP B. F. An electron microscope study of the uptake, transport, and storage of colloidal materials by the cells of the vertebrate nephron. J Ultrastruct Res. 1961 Jun;5:291–310. doi: 10.1016/s0022-5320(61)90021-1. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES